Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Zhonghua Yi Xue Za Zhi ; 102(32): 2500-2505, 2022 Aug 30.
Article in Chinese | MEDLINE | ID: mdl-36008320

ABSTRACT

Objective: To study the value of molecular classification in postoperative adjuvant therapy for endometrial carcinoma (EC). Methods: Patients with stage Ⅰ EC who underwent surgical-pathological staging surgery and molecular classification in Peking University Third Hospital from January 2020 to April 2022 were retrospectively analyzed. The influence of different molecular types of EC on postoperative adjuvant therapy were studied. Results: The age of the 196 patients was (55.1±10.2) years old, and the body mess index (BMI) was (26.0±3.9) kg/m2. Molecular classification was performed in 196 stage ⅠEC patients, identifying the 4 subgroups: POLE mutation (POLEmut, n=19, 9.7%), mismatch repair-deficient (dMMR, n=28, 14.3%), no-specific molecular profile (NSMP, n=142, 72.4%) and p53 mutation (p53abn, n=7, 3.6%). Molecular classification was one of the influencing factors on the selection of postoperative adjuvant therapy for EC patients (P=0.003). POLEmut, dMMR and NSMP subtypes were not the variables in selecting radiotherapy or combined chemo-radiotherapy postoperatively. p53abn subtype was not the influencer for radiotherapy, however, it may contribute to the selection of combined chemo-radiotherapy postoperatively (P<0.001). Conclusion: The p53abn subtype in the molecular classification is an influencing factor in the selection of combined chemo-radiotherapy for EC patients postoperatively.


Subject(s)
Endometrial Neoplasms , Tumor Suppressor Protein p53 , Adult , Aged , Combined Modality Therapy , Endometrial Neoplasms/genetics , Endometrial Neoplasms/pathology , Female , Humans , Middle Aged , Mutation , Retrospective Studies , Tumor Suppressor Protein p53/genetics
4.
Rev Sci Instrum ; 89(1): 013103, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29390657

ABSTRACT

We present a coherent bichromatic laser system with low phase noise. An optical injection process is used to generate coherent laser beams with a frequency difference of 9.192 631 77 GHz using an electro-optical modulator. An optical phase-locked loop is then applied to reduce the phase noise. The phase noise of the beat note is -41, -81, -98, -83, and -95 dBrad2/Hz at the offset frequencies of 1 Hz, 100 Hz, 1 kHz, 10 kHz, and 1 MHz, respectively. Compared to a system that uses optical injection alone, the phase noise is reduced by up to 20-30 dB in the low-frequency range, and the intermodulation effect on the continuous atomic clock is reduced by an order of magnitude. This configuration can adjust the intensities and polarizations of the laser beams independently and reduce the phase noise caused by environmental disturbances and optical injection, which may be useful for application to atomic coherence experiments.

5.
Allergy ; 70(12): 1613-21, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26332371

ABSTRACT

BACKGROUND: Chronic rhinosinusitis (CRS) has a broad range of comorbidities. Due to a lack of longitudinal studies, it is not known whether these comorbidities cause CRS, are promoted by CRS, or share a systemic disease process with CRS. OBJECTIVE: The objective of this study was to determine the risk of incident disease within 5 years after a new diagnosis of CRS with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP). METHODS: We conducted a case-control study nested within the longitudinal cohort of primary care patients in the Geisinger Clinic using electronic health record data. We evaluated incident disease over 5 years in newly diagnosed CRSwNP and CRSsNP cases compared to controls using multivariable Cox regression models. RESULTS: CRSsNP (n = 3612) cases were at greater risk (HR, 95% confidence interval) than controls for incidence of: upper airway diseases, including adenotonsillitis (3.29, 2.41-4.50); lower aerodigestive tract diseases, including asthma (2.69, 2.14-3.38); epithelial conditions, including atopic dermatitis (2.75, 1.23-6.16); and hypertension (1.38, 1.19-1.61). CRSwNP (n = 241) cases were at greater risk for obesity than controls (1.74, 1.08-2.80), but CRSwNP was not associated with other diseases. CONCLUSION: The risk of other diseases associated with CRS adds to the burden of an already highly burdensome condition, and suggests either that CRS promotes onset of other diseases or is an indicator of systemic disease processes. Different patterns of association with diseases by CRS phenotype may be due to CRSwNP sample size limitations or reflect a different pattern of disease onset by phenotype. These findings have implications for screening guidelines and care of CRS patients.


Subject(s)
Comorbidity , Rhinitis/complications , Rhinitis/epidemiology , Sinusitis/complications , Sinusitis/epidemiology , Adolescent , Adult , Aged , Case-Control Studies , Child , Child, Preschool , Chronic Disease , Female , Humans , Incidence , Infant , Infant, Newborn , Longitudinal Studies , Male , Middle Aged , Nasal Polyps/complications , Nasal Polyps/epidemiology , Proportional Hazards Models , Risk , Young Adult
6.
Int J Radiat Biol ; 60(6): 907-16, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1682403

ABSTRACT

Mice were gavaged with zinc-65 solution, 8.6-19.3 kBq per mouse, and the whole-body retention and organ content of zinc-65 were measured at different times after administration. The age-dependence of the fractional absorption of zinc-65 from the gastrointestinal tract (f1), the endogenous faecal excretion fraction of zinc-65 (EFEF), tissue distribution and whole-body retention were determined. The f1 values obtained were 0.86 +/- 0.15, 0.64 +/- 0.11, 0.52 +/- 0.07 and 0.39 +/- 0.02 in suckling, adolescent, young adult and older mice, respectively. The EFEF values determined were 0.083 +/- 0.008, 0.099 +/- 0.004, 0.122 +/- 0.018 and 0.144 +/- 0.005 of intraperitoneally injected zinc-65 in suckling, adolescent, young adult and older mice at administration. Zinc-65 mainly distributed in the liver, muscle, lung, kidneys and bone. In some tissues, there was an inverse relationship between the relative content of gavaged zinc-65 and the animal's age at administration. The whole-body biological half-lives of zinc-65 increased with animal age. The influence of the age-dependent variation of zinc-65 metabolism on internal dose and on radiation protection is discussed.


Subject(s)
Aging/metabolism , Metabolic Clearance Rate/physiology , Zinc Radioisotopes/metabolism , Administration, Oral , Animals , Animals, Newborn , Body Weight/drug effects , Feces/chemistry , Injections, Intraperitoneal , Intestinal Absorption/physiology , Kinetics , Mice , Mice, Inbred Strains , Organ Size/drug effects , Radiation Protection/standards , Tissue Distribution/physiology , Whole-Body Irradiation , Zinc Radioisotopes/analysis , Zinc Radioisotopes/pharmacokinetics , Zinc Radioisotopes/pharmacology
7.
Zhongguo Zhong Yao Za Zhi ; 14(8): 466-8, 510, 1989 Aug.
Article in Chinese | MEDLINE | ID: mdl-2508668

ABSTRACT

The present paper reports the contents of ursolic acid in Crataegus pinnatifida var. major before and after processing determined by CS-920 TLC scanner: 0.274% and 0.265%, coefficients of variation 1.180% and 1.150% respectively. This method is simple, fast, reproducible and highly sensitive.


Subject(s)
Anti-Infective Agents/analysis , Drugs, Chinese Herbal/analysis , Chromatography, Thin Layer , Hot Temperature , Triterpenes , Ursolic Acid
SELECTION OF CITATIONS
SEARCH DETAIL